Optimizing Prostate Cancer Outcomes in Clinical Trials with Innovative PET Radiotracers
Prostate cancer is a significant health concern for men, being the most prevalent non-dermatologic cancer and the second leading cause of cancer-related deaths. Advances in imaging, particularly positron emission tomography (PET), along with radioligand therapy (RLT) using specific tracers, are… Read More